Tech Company Financing Transactions
Moleculera Labs Funding Round
Moleculera Labs closed a $700 thousand venture capital round on 10/4/2013. Backers included i2e Enterprise Oklahoma Fund and private investors.
Transaction Overview
Company Name
Announced On
10/4/2013
Transaction Type
Venture Equity
Amount
$700,000
Round
Undisclosed
Investors
i2e Enterprise Oklahoma Fund (Lead Investor)
Proceeds Purpose
This important financing round gives us the ability to help even more families, and to expand our services to meet the critical need for testing of these very sick children in the U.S. and world-wide.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
755 Research Pkwy. 410
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
Moleculera Labs provides personalized clinical testing services for individuals suspected of suffering from PANDAS/PANS, which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders (OCD) and sometimes Autism Spectrum Disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Craig Shimasaki
Chief Financial Officer
Fred Hiller
Chief Scientific Officer
Madeleine Cunningham
Browse more venture capital transactions:
Prev: 10/4/2013: Koality venture capital transaction
Next: 10/4/2013: Luminate Health venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs